Sean Pinney to Glucosides
This is a "connection" page, showing publications Sean Pinney has written about Glucosides.
Connection Strength
0.364
-
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2021 01 26; 77(3):243-255.
Score: 0.193
-
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity? Cardiovasc Drugs Ther. 2019 02; 33(1):87-95.
Score: 0.171